The International Society for Neonatal Screening (ISNS) is recognized worldwide for its contributions to the detection of neonatal conditions and the prevention of their adverse outcomes through excellence in neonatal screening.
The mission of ISNS is to enhance the quality of neonatal screening and medical services through dissemination of information, guidelines and best practices that benefit all family members and their babies by helping to ensure protection of babies from life-quality threatening conditions, such as phenylketonuria, congenital hypothyroidism, severe combined immunodeficiency, cystic fibrosis, hemoglobinopathies and many others.
The Association of Public Health Laboratories (APHL) works to strengthen laboratory systems serving the public's health in the United States and globally.
- Vision: A healthier world through quality laboratory systems.
- Mission: Shape national and global health outcomes by promoting the value and contributions of public health laboratories and continuously improving the public health laboratory system and practice.
The German Society for Neonatal Screening (DGNS) is a scientific-medical specialist society in the field of neonatal screening.
The interdisciplinary orientation of DGNS provides a common platform for professional groups specializing in screening, diagnosis, therapy and post-care aiming to optimize and ensure high quality standards in neonatal screening.
The Japanese Society for Neonatal Screening (JSNS) was established in 1974 and consists of 440 members (as of 2020), including clinical physicians such as pediatricians, obstetricians or others, laboratory scientists and technicians, and researchers in the public health field or administrative personnel.The academic activity includes the development of testing and diagnostic methods, improvement of treatments, follow-up of patients, new target diseases, and international cooperation.
The UK Newborn Screening Laboratory Network (UKNSLN) is an association of NHS laboratories which provide screening services to newborn babies for a number of inherited and congenital diseases. We promote high standards of practice and encourage collaboration in newborn biochemical screening across the UK.